Skip to content
10-Q

Quarterly Report

LifeMD, Inc. LFMD LFMDP

0001641172-25-008864

← back to feed
Filed
May 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 5, 2025 45.45M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $34.39M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $35M
Stockholders Equity Q1 2025 · Mar 31, 2025 −$2.33M
Stockholders Equity Q1 2025 · Dec 31, 2024 −$5.49M
Current Liabilities Q1 2025 · Mar 31, 2025 $60.9M
Current Liabilities Q1 2025 · Dec 31, 2024 $60.26M
Total Liabilities Q1 2025 · Mar 31, 2025 $74.01M
Total Liabilities Q1 2025 · Dec 31, 2024 $76.51M
Current Assets Q1 2025 · Mar 31, 2025 $49.97M
Current Assets Q1 2025 · Dec 31, 2024 $48.73M
Total Assets Q1 2025 · Mar 31, 2025 $73.61M
Total Assets Q1 2025 · Dec 31, 2024 $72.46M
Shares Diluted Q1 2025 · Mar 31, 2024 39.24M sh
Capex Q1 2025 · Mar 31, 2024 $175.59K
Operating Cash Flow Q1 2025 · Mar 31, 2024 $5.2M
Sga Expense Q1 2025 · Mar 31, 2024 $15.31M
Net Income Q1 2025 · Mar 31, 2024 −$6.77M
Operating Income Q1 2025 · Mar 31, 2024 −$6.17M
Gross Profit Q1 2025 · Mar 31, 2024 $39.54M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $4.6M
Revenue Q1 2025 · Mar 31, 2024 $44.14M
Stock Issued Q1 2025 · Nov 15, 2023 79.33K sh